Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
Income Statement
Earnings Waterfall
Luoxin Pharmaceuticals Group Stock Co Ltd
Revenue
|
1.6B
CNY
|
Cost of Revenue
|
-1.4B
CNY
|
Gross Profit
|
239.1m
CNY
|
Operating Expenses
|
-1.5B
CNY
|
Operating Income
|
-1.3B
CNY
|
Other Expenses
|
325.6m
CNY
|
Net Income
|
-957.7m
CNY
|
Income Statement
Luoxin Pharmaceuticals Group Stock Co Ltd
Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||
Revenue |
584
N/A
|
610
+4%
|
618
+1%
|
639
+3%
|
637
0%
|
687
+8%
|
732
+7%
|
777
+6%
|
828
+7%
|
834
+1%
|
857
+3%
|
863
+1%
|
6 211
+620%
|
7 817
+26%
|
9 680
+24%
|
11 178
+15%
|
7 589
-32%
|
7 063
-7%
|
6 338
-10%
|
6 320
0%
|
6 096
-4%
|
6 563
+8%
|
6 860
+5%
|
6 830
0%
|
6 478
-5%
|
6 913
+7%
|
6 177
-11%
|
5 155
-17%
|
3 588
-30%
|
2 073
-42%
|
1 700
-18%
|
1 644
-3%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||
Cost of Revenue |
(422)
|
(437)
|
(441)
|
(455)
|
(459)
|
(495)
|
(520)
|
(549)
|
(580)
|
(590)
|
(627)
|
(642)
|
(1 934)
|
(2 591)
|
(3 082)
|
(3 639)
|
(2 802)
|
(2 775)
|
(2 723)
|
(2 803)
|
(2 848)
|
(3 050)
|
(3 225)
|
(3 338)
|
(3 232)
|
(3 448)
|
(3 295)
|
(3 073)
|
(2 694)
|
(2 123)
|
(1 770)
|
(1 405)
|
|
Gross Profit |
162
N/A
|
173
+6%
|
177
+2%
|
184
+4%
|
178
-3%
|
192
+8%
|
212
+10%
|
228
+8%
|
248
+9%
|
244
-2%
|
230
-6%
|
221
-4%
|
4 277
+1 839%
|
5 226
+22%
|
6 599
+26%
|
7 540
+14%
|
4 786
-37%
|
4 288
-10%
|
3 615
-16%
|
3 517
-3%
|
3 248
-8%
|
3 513
+8%
|
3 635
+3%
|
3 492
-4%
|
3 246
-7%
|
3 465
+7%
|
2 882
-17%
|
2 082
-28%
|
894
-57%
|
(50)
N/A
|
(69)
-38%
|
239
N/A
|
|
Operating Income | |||||||||||||||||||||||||||||||||
Operating Expenses |
(75)
|
(82)
|
(86)
|
(84)
|
(86)
|
(91)
|
(96)
|
(99)
|
(109)
|
(99)
|
(103)
|
(108)
|
(3 764)
|
(4 586)
|
(5 773)
|
(6 603)
|
(4 030)
|
(3 539)
|
(2 937)
|
(2 807)
|
(2 780)
|
(2 996)
|
(3 042)
|
(2 886)
|
(2 668)
|
(2 964)
|
(2 759)
|
(2 530)
|
(2 343)
|
(1 660)
|
(1 514)
|
(1 522)
|
|
Selling, General & Administrative |
(49)
|
(72)
|
(76)
|
(78)
|
(56)
|
(83)
|
(89)
|
(91)
|
(70)
|
(97)
|
(101)
|
(97)
|
(3 356)
|
(4 102)
|
(5 203)
|
(5 940)
|
(3 627)
|
(3 219)
|
(2 624)
|
(2 525)
|
(2 405)
|
(2 691)
|
(2 745)
|
(2 589)
|
(2 339)
|
(2 698)
|
(2 587)
|
(2 391)
|
(2 178)
|
(1 481)
|
(1 317)
|
(1 316)
|
|
Research & Development |
(22)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
(9)
|
(386)
|
(515)
|
(623)
|
(719)
|
(383)
|
(405)
|
(382)
|
(360)
|
(326)
|
(329)
|
(326)
|
(324)
|
(280)
|
(313)
|
(299)
|
(267)
|
(171)
|
(187)
|
(143)
|
(124)
|
|
Depreciation & Amortization |
(3)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(76)
|
0
|
0
|
0
|
(94)
|
0
|
0
|
0
|
(100)
|
0
|
0
|
0
|
(108)
|
0
|
0
|
0
|
(145)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(1)
|
(10)
|
(10)
|
(6)
|
(1)
|
(9)
|
(8)
|
(7)
|
(0)
|
(1)
|
(2)
|
(2)
|
53
|
32
|
53
|
55
|
74
|
85
|
70
|
78
|
50
|
25
|
29
|
26
|
58
|
48
|
127
|
128
|
151
|
8
|
(54)
|
(82)
|
|
Operating Income |
87
N/A
|
90
+4%
|
90
+0%
|
100
+10%
|
92
-8%
|
101
+9%
|
116
+15%
|
130
+12%
|
140
+8%
|
145
+4%
|
127
-13%
|
113
-11%
|
513
+355%
|
640
+25%
|
826
+29%
|
937
+13%
|
756
-19%
|
749
-1%
|
679
-9%
|
710
+5%
|
468
-34%
|
517
+10%
|
593
+15%
|
605
+2%
|
578
-5%
|
501
-13%
|
123
-75%
|
(448)
N/A
|
(1 450)
-224%
|
(1 710)
-18%
|
(1 583)
+7%
|
(1 283)
+19%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||
Interest Income Expense |
4
|
(2)
|
1
|
6
|
22
|
24
|
16
|
9
|
(6)
|
(17)
|
(6)
|
10
|
50
|
57
|
38
|
22
|
(32)
|
(45)
|
(40)
|
(44)
|
(42)
|
(33)
|
(62)
|
(75)
|
(98)
|
(109)
|
(111)
|
(129)
|
(113)
|
47
|
58
|
91
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
(0)
|
(2)
|
0
|
0
|
0
|
(12)
|
(5)
|
(9)
|
(9)
|
(4)
|
0
|
(0)
|
1
|
103
|
2
|
4
|
3
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
4
|
3
|
7
|
4
|
3
|
3
|
(1)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
7
|
3
|
7
|
9
|
1
|
(0)
|
(10)
|
(14)
|
(6)
|
(15)
|
(10)
|
(3)
|
9
|
6
|
4
|
(3)
|
(3)
|
(1)
|
9
|
15
|
|
Pre-Tax Income |
95
N/A
|
92
-3%
|
98
+7%
|
109
+12%
|
116
+6%
|
127
+9%
|
130
+3%
|
137
+5%
|
134
-2%
|
128
-4%
|
121
-6%
|
122
+1%
|
571
+367%
|
700
+23%
|
871
+24%
|
967
+11%
|
724
-25%
|
705
-3%
|
629
-11%
|
653
+4%
|
409
-37%
|
464
+13%
|
513
+11%
|
518
+1%
|
485
-6%
|
398
-18%
|
17
-96%
|
(579)
N/A
|
(1 463)
-153%
|
(1 661)
-14%
|
(1 513)
+9%
|
(1 174)
+22%
|
|
Net Income | |||||||||||||||||||||||||||||||||
Tax Provision |
(13)
|
(12)
|
(13)
|
(15)
|
(16)
|
(17)
|
(18)
|
(19)
|
(18)
|
(17)
|
(16)
|
(15)
|
(46)
|
(60)
|
(91)
|
(105)
|
(71)
|
(76)
|
(55)
|
(56)
|
(66)
|
(70)
|
(94)
|
(84)
|
(64)
|
(53)
|
(11)
|
62
|
205
|
215
|
202
|
113
|
|
Income from Continuing Operations |
82
|
79
|
85
|
94
|
100
|
110
|
113
|
118
|
116
|
111
|
105
|
107
|
525
|
641
|
780
|
862
|
654
|
628
|
575
|
596
|
343
|
394
|
419
|
434
|
422
|
345
|
7
|
(517)
|
(1 258)
|
(1 447)
|
(1 311)
|
(1 061)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
(23)
|
(28)
|
(34)
|
(20)
|
(8)
|
(19)
|
(19)
|
(20)
|
(26)
|
(15)
|
(19)
|
(16)
|
(15)
|
(16)
|
(11)
|
32
|
49
|
77
|
103
|
|
Net Income (Common) |
82
N/A
|
79
-3%
|
85
+7%
|
94
+11%
|
100
+6%
|
110
+9%
|
113
+3%
|
118
+5%
|
116
-2%
|
111
-4%
|
105
-6%
|
107
+3%
|
512
+377%
|
618
+21%
|
752
+22%
|
828
+10%
|
634
-23%
|
620
-2%
|
556
-10%
|
578
+4%
|
322
-44%
|
368
+14%
|
404
+10%
|
415
+3%
|
406
-2%
|
330
-19%
|
(9)
N/A
|
(528)
-5 606%
|
(1 226)
-132%
|
(1 397)
-14%
|
(1 234)
+12%
|
(958)
+22%
|
|
EPS (Diluted) |
0.32
N/A
|
0.31
-3%
|
0.27
-13%
|
0.27
N/A
|
0.32
+19%
|
0.33
+3%
|
0.33
N/A
|
0.34
+3%
|
0.34
N/A
|
0.33
-3%
|
0.31
-6%
|
0.32
+3%
|
1.51
+372%
|
1.82
+21%
|
2.21
+21%
|
2.3
+4%
|
0.59
-74%
|
0.42
-29%
|
0.38
-10%
|
0.4
+5%
|
0.22
-45%
|
0.26
+18%
|
0.29
+12%
|
0.29
N/A
|
0.28
-3%
|
0.23
-18%
|
0
N/A
|
-0.37
N/A
|
-1.13
-205%
|
-1.28
-13%
|
-1.13
+12%
|
-0.88
+22%
|